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The crystallographic phase problem [Muirhead & Perutz
(1963), Nature (London), 199, 633–638] remains the single
major impediment to obtaining a three-dimensional structure
of a macromolecule once suitable crystals have been obtained.
Recently, it was found that it was possible to solve the
structure of a 142-nucleotide L1 ligase ribozyme heterodimer
that possesses no noncrystallographic symmetry without
heavy-atom derivatives, anomalous scattering atoms or other
modiﬁcations and without a model of the tertiary structure of
the ribozyme [Robertson & Scott (2007), Science, 315, 1549–
1553]. Using idealized known RNA secondary-structural
fragments such as A-form helices and GNRA tetraloops in
an iterative molecular-replacement procedure, it was possible
to obtain an estimated phase set that, when subjected to
solvent ﬂattening, yielded an interpretable electron-density
map with minimized model bias, allowing the tertiary structure
of the ribozyme to be solved. This approach has also proven
successful with other ribozymes, structured RNAs and RNA–
protein complexes.
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1. Introduction
The macromolecular X-ray crystallographic phase problem
must be solved in order to compute an electron-density map
(the image of the molecule) from the observed X-ray
diffraction pattern (Taylor, 2003). This requires an estimation
of the phase angle associated with each of many thousands of
experimentally measured diffraction amplitudes and is thus an
intractable computational problem. Instead, phase estimates
must be obtained experimentally by using isomorphous
replacement of heavy atoms or covalent incorporation of
anomalous scattering atoms such as Br or by using molecular
replacement, in which a highly homologous three-dimensional
structure, typically better than 1.5 A ˚ r.m.s.d., is used as a
search model (Chen et al., 2000; Qian et al., 2007). In the case
of complex RNAs with tertiary structures, such as tRNA,
ribozymes and other structural RNAs, experimental estima-
tion of phases requires successful soaking and binding of
heavy-metal ions to the RNA structure or synthetic incor-
poration of modiﬁed nucleotides such as 5-bromouracil
(5BrU), procedures that may be laborious and unsuccessful.
Successful molecular replacement requires a homologous
prior high-resolution three-dimensional structure and has thus
been of limited utility for solving novel RNA structures.
Hence, if neither isomorphous modiﬁcations nor homologous
three-dimensional structures are readily available, the macro-
molecular phase problem becomes a major impediment to
solving RNA crystal structures (Keel et al., 2007).Faced with just such a predicament in the case of the
71-nucleotide L1 ligase ribozyme (Fig. 1a), we developed an
approach for solving RNA structures having novel folds. The
crystallographic asymmetric unit contains two copies of the
ligase ribozyme (142 nucleotides) in radically different
conformations, so despite the dimeric asymmetric unit no
apparent noncrystallographic symmetry was available to
exploit. The ribozyme crystallized as a covalently closed
71-nucleotide circular adduct, making synthetic incorporation
of 5BrU impossible, and transcripts incorporating 11 5BrU
yielded crystals that diffracted quite poorly, making the
identiﬁcation and use of 22 Br sites in the asymmetric unit to
estimate phases in an isomorphous difference or MAD
experiment impossible.
Unlike the tertiary structures of RNAs, many RNA
secondary-structural elements are fairly easy to predict based
upon sequence complementarity and phylogenetic conserva-
tion patterns (Eddy, 2004). For example, most of the RNA
secondary-structural elements in the ribosome were predicted
correctly long before the crystal structures became available
(Noller et al., 1981; Noller & Woese, 1981; Woese et al., 1980).
In addition, these structural elements typically conform fairly
closely to idealized structural motifs, such as ideal A-form
Watson–Crick helices, stable tetraloops (Antao & Tinoco,
1992) and the like. High-resolution three-dimensional struc-
tures of these individual motifs are available in the Protein
Data Bank and can also be constructed de novo in molecular-
modeling software packages such as Coot (Emsley & Cowtan,
2004). Modeling the RNA stem-loop regions in the L1 ligase
was therefore very straightforward. The GNRA tetraloop is a
canonical nonhelical RNA secondary structure that is very
common and thermodynamically favorable (Varani, 1995).
RNA tetraloops that have a G at position 1, any residue (N) at
position 2, a purine (R) at position 3 and an A at position 4 all
adopt the same thermodynamically stable structure. Many
canonical GNRA tetraloop structures are available in the
PDB; we chose a GUAA tetraloop and ﬂanking residues from
a minimal hammerhead ribozyme (Scott et al., 1996) as a
template and generated canonical A-form helices within Coot.
Our original intent was to obtain a very approximate phase
estimate based on a partial molecular-replacement solution
and to then use these phases to discover the positions of the 22
Br sites using a conventional difference
Fourier. The quality of the Br-derivative
data set, however, proved to be insufﬁ-
cient for phasing, but the phases
obtained from the iterative phasing
procedure described here nonetheless
enabled us to solve the structure. (The
weakly diffracting Br-derivative data set
was, however, of sufﬁcient quality to
enable us to check the ﬁnal structure for
consistency; the Br sites all appeared
proximal to the 5-carbon position on
each of the uracil bases.)
2. Experimental procedures
The main steps of the procedure
employed to solve the L1 ligase ribo-
zyme structure are outlined in Fig. 2 and
are described in the accompanying
caption. Brieﬂy, a set of model frag-
ments is generated for simultaneous
piecewise molecular replacement in
Phaser (McCoy et al., 2005) using a
native RNA data set (Table 1). The best
solution from Phaser is then edited in
Coot to remove steric clashes and
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Figure 1
The predicted secondary structure of the 71-nucleotide L1 ligase ribozyme. Sequences thought to be
involved in canonical Watson–Crick (or wobble) base pairing or corresponding to the known
GNRA tetraloop structure are colored in blue, green and yellow (a). Idealized models of these
sequences were generated within Coot (b). The GAAA tetraloop was modeled using the previously
determined minimal hammerhead RNA GUAA structure obtained from the PDB (299d).
Table 1
Data collection and processing.
Values in parentheses are for the outer shell.
Space group P21
Unit-cell parameters (A ˚ ,  ) a = 45.3, b = 100.0, c = 71.9,
 =  = 90,  = 104.4
X-ray data wavelength (A ˚ ) 0.9840
Low-resolution limit (A ˚ ) 100.00 (2.74)




 ) 0.060 (0.626)
Rmeas (all I
+ and I
 ) 0.056 (0.615)
Rp.i.m. (within I
+/I
 ) 0.040 (0.413)
Rp.i.m. (all I
+ and I
 ) 0.028 (0.299)
Fractional partial bias  0.022 ( 0.116)
Total No. of observations 77375 (11410)
Total unique observations 19071 (2767)
Mean I/(I) 20.2 (2.5)
Completeness (%) 99.5 (99.9)
Multiplicity 4.1 (4.1)research papers
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Figure 2
Flowchart of the procedure used to solve
the L1 ligase structure. An initial
assembly of modeled RNA fragments
(helices, loops) is used in combination
with a native data set (Fobs) to obtain a
starting molecular-replacement solution
in Phaser (round_1.mtz and round_1.pdb).
This solution is examined in Coot;a l l
steric clashes are removed by manual
editing and any nucleotide that does not
reside in strong electron density in the
A-weighted 2Fo   Fc map is manually
excised. The remaining model is then
positionally reﬁned using REFMAC
(which can be performed within Coot)
and any unoccupied density is modeled
and reﬁned in Coot. In addition, a new
helical fragment (typically ﬁve base pairs
of A-form helix) for a subsequent itera-
tion of molecular replacement is gener-
ated. Using the edited and reﬁned model
as a ﬁxed partial model, the next (ith)
round of molecular replacement in
Phaser and subsequent editing and reﬁne-
ment is carried out with the new helical
fragment. This cycle is repeated until no
more helical fragments can be added. At
this point, at the Nth cycle, the
best molecular-replacement solution
(round_N.mtz and round_N.pdb) is used
to generate a solvent-ﬂattened electron-
density map. The model itself
(round_N.pdb) in the case of the L1
ligase was clearly ﬂawed in that the
positioning of the secondary-structural
elements was not consistent with the
primary sequence and it was clear that
the ‘solution’ was one in which the
secondary-structural fragments were
generically positioned by Phaser without
regard to the detailed sequence-based
structure. For this reason, the model
(round_N.pdb) was discarded and the
calculated phase probability distributions
were converted to Hendrickson–Latt-
mann coefﬁcients within CCP4 and were
then imported into CNS along with the
native data set (Fobs) and treated as if
they were experimentally determined
MIR phases to be solvent-ﬂattened. We
employed solvent-ﬂipping, using a solvent
content of 50% predicted by the xtriage
module of PHENIX, which simulta-
neously improved the quality of the
electron-density map and helped to mini-
mize model bias. The resulting map,
pictured in Fig. 3, was then used to build
the ﬁnal model from scratch (i.e. without
reference to the discarded molecular-
replacement solution round_N.pdb), as
if the map had been derived from
experimental MIR phases. The resulting
structure was then checked against a
composite-OMIT map generated within
CNS in which 10% of the model was
omitted from each element of the compo-
site and phases were regenerated from a
standard simulated-annealing procedure
with a starting temperature of 4000 K.obvious positional errors (atoms placed in weak or no
density). The remaining model consisting of several disjointed
fragments is then reﬁned and used as a ﬁxed partial model for
a subsequent round of molecular replacement in which a
single additional structural fragment is positioned. This solu-
tion is then edited as before and is combined with the previous
model. The procedure is repeated iteratively until no addi-
tional single fragments can be added successfully. The model
consisting of an accumulated set of fragments is completely
discarded, but the phases are retained and are subsequently
solvent-ﬂattened within CNS (Bru ¨nger et al., 1998) to generate
a ‘pseudo-MIR map’ that is then used as a starting point for
tracing, modeling and reﬁning the genuine structure.
2.1. Modeling structural fragments
The secondary structure of the L1 ligase was established
well before the crystal structure was solved (Robertson &
Ellington, 1999). The predicted secondary structure for the
sequence used in crystallization is shown in Fig. 1(a) and
consists of three GNRA tetraloops, several regions of
predicted canonical A-form Watson–Crick paired helices,
‘internal bulge’ regions of unpredicted structure and regions
of non-Watson–Crick pairing (Robertson & Scott, 2007).
We constructed four model fragments corresponding to the
color-coded secondary-structural elements, as shown in
Fig. 1(b). The yellow and green segments were modeled using
a GNRA tetraloop structure (PDB code 299d) as a template,
extended with canonical A-form model helices within Coot.
The blue region was modeled as a canonical A-form helix
within Coot. No attempt was made to model the sequences
shown in white and no attempt was made to orient the four
fragments with respect to one another in three dimensions.
Instead, the four fragments were together used simultaneously
but as independent rigid bodies to comprise a single starting
model having 24 degrees of freedom (three rotational and
three translational degrees of freedom for each of four rigid
bodies) for molecular replacement.
2.2. Molecular replacment
The unit-cell contents of the L1 ligase ribozyme were esti-
mated using the xtriage module of PHENIX (Adams et al.,
2002, 2004) and were found to be consistent with either one,
two or three 71-nucleotide ribozyme molecules in the asym-
metric unit. No noncrystallographic symmetry was detected,
consistent with either one molecule in the asymmetric unit or
multiple molecules in the asymmetric unit adopting different
conformations.
Molecular replacement was carried out using the program
Phaser distributed with the CCP4 (Collaborative Computa-
tional Project, Number 4, 1994; Winn, 2003) and PHENIX
(Adams et al., 2002, 2004) packages. Three initial searches
were carried out in separate but parallel Phaser runs.
The ﬁrst molecular-replacement attempt assumed that there
was only one ribozyme molecule per crystallographic asym-
metric unit and thus used the four RNA fragments described
above together simultaneously, a single starting model having
24 degrees of freedom.
The second independent molecular-replacement attempt
instead assumed that there were two molecules per asym-
metric unit and thus used two copies of each set of four
fragments, or eight rigid-body fragments, comprising a single
starting model having 48 degrees of freedom in total.
The third molecular-replacement attempt used three copies
of each fragment or 12 rigid-body fragments, comprising a
single starting model having 72 degrees of freedom in total.
In each independent trial, Phaser produced a best estimate
phased reﬂection and PDB ﬁle and these were visually
inspected within Coot. Using the molecular-replacement
phase set and PDB ﬁle, A-weighted 2Fo   Fc and difference
Fouriers were calculated and displayed in Coot.
The initial solution obtained from the ﬁrst molecular-
replacement trial consisting of four rigid-body fragments
appeared to yield the most promising estimated phases,
although several nucleotides were observed to have very poor
electron density and several others involved steric clashes
between fragments. The offending nucleotides were deleted
from the initial solution within Coot, so that the manually
edited model contained no major steric clashes and every
remaining nucleotide was contained in well deﬁned electron
density in the initial 2Fo   Fc map. A subsequent round of
minimization carried out in REFMAC (Murshudov et al.,
1997) within Coot produced a reﬁned model structure and an
A-weighted 2Fo   Fc map in which additional recognizable
features, such as nucleotide base pairs, began to emerge. Based
on this criterion, we judged that the initial model possessed at
least some legitimate predictive phasing power.
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Figure 3
The solvent-ﬂattened ‘pseudo-MIR’ electron-density map. The electron-
density map was generated in CNS using an initial phase probability
distribution obtained from the iterative RNA-fragment molecular-
replacement procedure outlined in Fig. 2 and described in the
accompanying caption and in the main text.2.3. Iterative model building
Using the edited solution from the ﬁrst molecular-replace-
ment trial, corresponding to one 71-nucleotide ribozyme
molecule in the crystallographic asymmetric unit, as a starting
point, we carried out subsequent rounds of molecular
replacement and reﬁnement by iteratively supplying indivi-
dual helical or stem-loop fragments to Phaser, along with the
edited starting model, allowing Phaser to position the addi-
tional RNA structural fragment. Although solutions often
involved considerable steric clashes, it was noteworthy that
helical fragments were often positioned in such a way as to
bridge gaps in the initial disjoined model. After each iteration,
the new combined solution was visually inspected; residues
involved in steric clashes or inhabiting weak or nonexistent
electron density were deleted and the edited model was then
further reﬁned. Using this procedure, about 75% of the RNA,
corresponding to a dimeric asymmetric unit of 142 nucleotides,
was eventually accounted for within the iteratively assembled
model. The actual sequence bore no sensible correspondence
to Fig. 1(a), but it was clear that the generic positions of the
tetraloops and helical regions had been successfully identiﬁed
by Phaser.
2.4. Calculating phases
After further positional reﬁnement in REFMAC or
PHENIX’s reﬁne module and editing of the model to remove
residues involved in steric clashes or in weak density, the
phase estimates calculated from the model consisting of the
remaining assembled helical fragments were converted using
the CCP4 program HLTOFOM (Collaborative Computa-
tional Project, Number 4, 1994) to Hendrickson–Lattmann
coefﬁcients and these phase probability distributions, together
with the experimentally measured amplitudes, were treated as
if they were an initial MIR phase set and were subjected to
solvent-ﬂattening (in solvent-ﬂipping mode;
Abrahams & Leslie, 1996) within CNS to
minimize the model bias and to improve the
quality of the estimated phases. A solvent
content of 50% was employed, consistent
with 142 nucleotides of RNA per asym-
metric unit.
The resulting solvent-ﬂattened electron-
density map (Fig. 3) was then treated as if it
was an experimentally phased map and was
skeletonized and then traced with polyC
within Coot, with no reference to the
discarded prior model structure. The quality
of this map was such that purines were
readily distinguishable from pyrimidines
and in many cases an adenine could be
distinguished from a guanosine. These
features, as well as the distinctive GNRA
tetraloop density, enabled the construction
and reﬁnement of two 71-nucleotide ribo-
zyme monomers without any sequence
ambiguities (Fig. 4). The ﬁnal reﬁned struc-
ture and accompanying structure-factor amplitudes are
available from the PDB (PDB code 2oiu).
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Figure 4
The ﬁnal reﬁned structure of the L1 ligase heterodimer (PDB code 2oiu).
The ﬁnal reﬁned structure as described in detail in Robertson & Scott
(2007). Each molecule varies from blue to red as one progresses in the 50
to 30 direction. The red/blue interface denotes the ligation-site junction.
Figure 5
The initial map. The A-weighted 2Fo   Fc map, contoured at 2, produced from the initial
four-fragment molecular-replacement solution. Additional helical density and some nucleotide
base density is apparent in regions not modeled with the RNA fragments, indicating that the
partial model possesses some degree of veracity and predictive phasing power. The color
scheme is the same as that used in Fig. 1.3. Results
3.1. A small subset of fragments works best
Although two ribozymes occupy the asymmetric unit of the
crystal, simultaneous molecular replacement with one set of
four rigid-body fragments, rather than two sets (eight rigid
bodies), yielded a better initial solution (and, in combination
with the apparent absence of noncrystallographic symmetry,
brieﬂy led us to a false conclusion that only one molecule was
present in the asymmetric unit rather than two). The solution
in which two sets of structural fragments were employed
resulted in most of the helices superimposed upon one
another, whereas the solution in which only one set of four
structural fragments was employed yielded a result in which
the four fragments were dispersed throughout the asymmetric
unit. The initial fragment model, comprising  1/3 of the total
mass of RNA actually present in the asymmetric unit,
possessed rotational and translational Z scores in Phaser of
only 3.3 and 3.9, respectively. One round of positional
reﬁnement in PHENIX’s reﬁne module, using all data from
31.3 to 2.6 A ˚ resolution, lowered the Rfree from 0.526 to 0.523
and the Rwork from 0.512 to 0.495. The statistics themselves
gave little hint of success.
However, examination of the A-weighted 2Fo   Fc map
that was produced from the initial four-fragment molecular-
replacement solution (Fig. 5) indicated reasonable electron
density covering the four RNA fragments at 2. More
signiﬁcantly, helical density appeared in unmodeled regions of
the map (Fig. 5) and at 1 several unmodeled nucleotide bases
were resolvable, indicating that the initial phases from the
RNA fragments possessed a degree of veracity and predictive
phasing power that could not be explained away as model bias.
This result inspired us to continue with molecular replacement
of individual RNA fragments, typically either A-form helices
having ﬁve or six base pairs or GNRA tetraloops, in an
iterative molecular-replacement procedure until about 75% of
the RNA had been modeled.
3.2. Calculation of a ‘pseudo-MIR’ map
After reﬁnement of the iteratively assembled fragments, the
lack of sensible sequence connectivity in an otherwise itera-
tively improving solution suggested that minimizing the
molecular-replacement model bias might help to further
improve the quality of the electron-density map. This was
performed by discarding the original model and treating the
molecular-replacement fragment (or partial model) phases as
if they were experimentally derived MIR phases that could be
improved by solvent ﬂattening. Our previous experiences
(Scott et al., 1995; Martick & Scott, 2006; Robertson et al.,
2005) suggested that the solvent-ﬂipping procedure, originally
introduced in the CCP4 SOLOMON package (Abrahams &
Leslie, 1996) and subsequently incorporated in CNS, produced
the best results with RNA experimental phases. Fig. 3 illus-
trates the quality of the solvent-ﬂattened ‘pseudo-MIR map’
produced by the solvent-ﬂipping subroutine within CNS, i.e.a
readily traceable electron-density map in which purines were
easily distinguished from pyrimidines and, in many cases,
guanines could be distinguished from adenines.
4. Discussion
To test whether the method is generally applicable to other
RNAs and RNA–protein complexes, we used X-ray data for
various ribozymes and RNA–protein complexes available
from the PDB. We were able to solve two different hammer-
head ribozyme structures, a minimal hammerhead (299d) and
full-length hammerhead (2oeu), and two hairpin ribozyme
structures, a minimal (2oue; MacElrevey et al., 2007) and a full-
length (1m5k) structure, the latter of which is an artiﬁcially
constructed complex between the hairpin ribozyme and the
U1A protein bound to an engineered binding site (Rupert &
Ferre ´-D’Amare ´, 2001), using the same procedure. In the case
of the full-length hairpin ribozyme bound to the U1A protein,
molecular replacement using only two copies of an unaltered
U1A RNA–protein complex (Oubridge et al., 1994) obtained
directly from the PDB (1urn, chains A and P) resulted in
successful positioning of both proteins and their associated
RNAs within the hairpin ribozyme asymmetric unit. One
round of positional reﬁnement within PHENIX produced a
reﬁned partial model with an Rwork of 0.443 and an Rfree of
0.450 from starting values of 0.468 and 0.470, respectively. This
map again revealed signiﬁcant helical density in unmodeled
regions, indicating that the partial model phases from frag-
ments comprising about  1/3 of the mass of the complex
possessed signiﬁcant predictive power. In contrast, molecular
replacement using four smaller helical fragments corre-
sponding to the four helices of the minimal hairpin ribozyme
yielded no such clear solution, even though the fragments
comprised  3/4 of the mass of the asymmetric unit. However,
molecular replacement using only helices 1 and 3 of the
minimal hairpin ribozyme yielded a better quality phase set
with predictive power.
A consistent result in each test case is that a comparatively
sparse subset of fragments yields a better initial molecular-
replacement solution. This result is in fact completely counter-
intuitive, given the usual assumption that a complete intact
and highly homologous three-dimensional structural model,
typically better than 1.5 A ˚ r.m.s.d., must be employed to
obtain a useful molecular-replacement solution (Chen et al.,
2000; Qian et al., 2007). In each test case, we found a highly
incomplete and fragmented model, consisting of about  1/3 of
the total mass of the whole crystallized macromolecule, with
no prior knowledge of how the fragments are arranged in
three-dimensional space, produced useful phases.
Although our tests have not been exhaustive, it appears that
many RNA crystal structures of a complexity originally
believed to be solvable only via MIR or MAD experimental
phasing methods can in fact be solved by molecular replace-
ment using a comparatively sparse sampling of RNA
secondary-structural fragments. Initial solutions incorporating
about  1/3 of the macromolecular contents of the unit cell
consistently gave rise to initial phase sets that upon im-
provement with additional iteratively placed helical fragments
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those with over  1/2 the unit-cell contents typically did not.
The fragment-basedsparse molecular-replacementapproach
we describe here has proven successful for moderately sized
ribozymes and RNA–protein complexes and notably led to the
only viable solution of the L1 ligase structure. Because heavy-
atom isomorphous replacement is not only laborious, but is
often a serious bottleneck in solving RNA and RNA–protein
complex crystal structures that often requires engineering
heavy-atom sites (Keel et al., 2007), we suggest that this
approach will likely be of considerable beneﬁt to practitioners
of high-throughput RNA crystallography and RNA structural
genomics.
We thank A. Szoke, B. Luisi, H. Noller, R. Read, the
members of the Scott research group and the RNA Center at
UCSC for helpful advice and critiques and the NIH (R01
043393) for funding. This procedure was inspired in part by
Professor Young-In Chi, who has used a similar helical frag-
ment approach to solve the structure of a hammerhead ribo-
zyme derived from the satellite tobacco ringspot virus RNA.
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